Clinical trials
Phase 1 Glomerulonephritis, IGA trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 9 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 9 |
| Not yet recruiting | 4 |
| Enrolling by invitation | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Children's Hospital of Zhejiang University School of Medicine | 5 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| Air Force Military Medical University, China | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Amgen | 1 |
| Arrowhead Pharmaceuticals | 1 |
| Beijing Immunochina Medical Science & Technology Co., Ltd. | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Chengdu Suncadia Medicine Co., Ltd. | 1 |
| Climb Bio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulonephritis, IGA | 28 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 5 |
| Autoimmune Diseases | 5 |
| Nephrotic Syndrome | 5 |
| Glomerulonephritis, Membranous | 3 |
| Glomerulosclerosis, Focal Segmental | 3 |
| Proteinuria | 3 |
| Renal Insufficiency, Chronic | 3 |
| Scleroderma, Systemic | 3 |
| Kidney Diseases | 2 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.